Greenrise Global Brands Inc released its earnings results on Nov 08, 2024. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.

Q: Is Greenrise Global Brands Inc overvalued?

According to Wall Street analysts Greenrise Global Brands Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Greenrise Global Brands Inc pay dividends?

Greenrise Global Brands Inc pays a Annually dividend of C$0.532 which represents an annual dividend yield of N/A. See more information on Greenrise Global Brands Inc dividends here

Q: How many shares outstanding does Greenrise Global Brands Inc have?

Greenrise Global Brands Inc has 47,236,040 shares outstanding.

Q: What happened to Greenrise Global Brands Inc’s price movement after its last earnings report?

Greenrise Global Brands Inc reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -50%.

2 Followers

XCX Stock Chart & Stats

Advanced Chart >

Day’s Range― - ―

52-Week Range<C$0.01 - C$0.10

Previous CloseN/A

Volume0.00

Average Volume (3M)4.07K

Market Cap

C$1.18M

Enterprise ValueC$5.02M

Total Cash (Recent Filing)$5.34M

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-2.90

Next Earnings

May 01, 2025

EPS EstimateN/A

Last Dividend Ex-Date

May 03, 2012

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding47,236,040

10 Day Avg. Volume200

30 Day Avg. Volume4,067

Standard Deviation0.53

R-Squared0.00089

Alpha0.07

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)-10.40

P/FCF Ratio7.10

Enterprise Value/Market Cap4.25

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda150.56

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Financials

Annual

Income Statement >

XCX FAQ

What was Greenrise Global Brands Inc’s price range in the past 12 months?

Greenrise Global Brands Inc lowest stock price was <C$0.01 and its highest was C$0.10 in the past 12 months.

What is Greenrise Global Brands Inc’s market cap?

Greenrise Global Brands Inc’s market cap is C$1.18M.

When is Greenrise Global Brands Inc’s upcoming earnings report date?

Greenrise Global Brands Inc’s upcoming earnings report date is May 01, 2025 which is in 100 days.

How were Greenrise Global Brands Inc’s earnings last quarter?

Greenrise Global Brands Inc released its earnings results on Nov 08, 2024. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.

Is Greenrise Global Brands Inc overvalued?

According to Wall Street analysts Greenrise Global Brands Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Greenrise Global Brands Inc pay dividends?

Greenrise Global Brands Inc pays a Annually dividend of C$0.532 which represents an annual dividend yield of N/A. See more information on Greenrise Global Brands Inc dividends here

What is Greenrise Global Brands Inc’s EPS estimate?

Greenrise Global Brands Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Greenrise Global Brands Inc have?

Greenrise Global Brands Inc has 47,236,040 shares outstanding.

What happened to Greenrise Global Brands Inc’s price movement after its last earnings report?

Greenrise Global Brands Inc reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -50%.

Which hedge fund is a major shareholder of Greenrise Global Brands Inc?

Currently, no hedge funds are holding shares in TSE:XCX

---

Company Description

Greenrise Global Brands Inc

AMP German Cannabis Group Inc is a European investment holding company whose primary investment through a subsidiary, a German importer of EU-GMP medical cannabis. The company goal is to provide medical cannabis formulations and dose delivery systems for German patients.

---